Trojan Bio

Harnessing viral specific immunity for fighting cancer

Yavne, Israel · Founded 2021

Headquarters
Yavne
Employees
1–10
Founded
2021
Business Model
B2B
Last Round
GrantJan 2023
Rounds
3

About

Trojan Bio is developing a novel class of therapeutic antibodies for the treatment of solid tumors. The company's Trojan antibody platform integrates viral peptides into antibody structures, enabling them to penetrate tumor microenvironments and activate the immune system from within—harnessing antiviral immunity to fight cancer. Trojan Bio won the Biomed Israel 2025 Startup Competition and is backed by Peregrine Ventures.

Summary

Trojan Bio is a Biotech company based in Yavne, Israel, founded in 2021. Its most recent funding was a Grant round in Jan 2023. Investors include NFX, Peregrine Ventures and Israel Innovation Authority.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2023

Sign up to see all 3 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trojan Bio on Indexed.vc
<a href="https://indexed.vc/companies/trojan-bio"><img src="https://indexed.vc/api/badge/company/trojan-bio" alt="Trojan Bio on Indexed.vc" width="260" height="76" /></a>